✦ LIBER ✦

565 Novel Infliximab (IFX) and Antibody-to-Infliximab (ATI) Assays are Predictive of Disease Activity in Patients With Crohn's Disease (CD)

✍ Scribed by Brian G. Feagan; Sharat Singh; Steven Lockton; Scott Hauenstein; Linda Ohrmund; Lisa J. Croner; Gordon R. Greenberg; William J. Sandborn; Paul J. Rutgeerts; Severine Vermeire

Book ID: 119433273
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 101 KB
Volume: 142
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(12)60430-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tu1173 Infliximab Trough Levels (IFX-Tl)

Tu1173 Infliximab Trough Levels (IFX-Tl) Are Higher in Patients With Inflammatory Bowel Disease (IBD)Treated With Immunosuppressives: Clinical Correlations of IFX-LT and Antibodies to Infliximab (ATI) in IBD

✍ Daperno, Marco; Lavagna, Alessandro; Fracchia, Mario; Guiotto, Cristina; Germano 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Tu1202 Correlation Between Infliximab Le

Tu1202 Correlation Between Infliximab Levels (IFX) and Antibody to Infliximab (ATI) in Pediatric Patients With Inflammatory Bowel Disease (IBD) With the Commercially Available Assay Using Electrochemilumescense

✍ Rivera Rivera, Edgardo D.; Liao, Chuanhong; Van't Hof, Kathleen; Mangatu, Thomas 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 806 KB

P069 A SINGLE CENTRE EXPERIENCE OF ADALI

P069 A SINGLE CENTRE EXPERIENCE OF ADALIMUMAB TREATMENT IN PATIENTS WITH LUMINAL AND FISTULIZING CROHN'S DISEASE (CD): DO ANTIBODIES TO INFLIXIMAB (ATIs) AFFECT CLINICAL OUTCOME?

✍ R.L. West; E.J. Kuipers; P. van der Toorn; E. Buster; P.B.F. Mensink; G.J. Wolbi 📂 Article 📅 2007 🏛 Oxford University Press ⚖ 59 KB

Effect of antibodies to infliximab on in

Effect of antibodies to infliximab on infusion reaction and clinical response in patients with fistulizing Crohn's disease receiving maintenance treatment with infliximab

✍ Wagner, Carrie; Ford, Joyce; Marsters, Paul; Travers, Suzanne; Bao, Weihang; Dev 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Severe Disease Activity and Cytomegalovi

Severe Disease Activity and Cytomegalovirus Colitis Are Predictive of a Nonresponse to Infliximab in Patients with Ulcerative Colitis

✍ Park, Sang Hyoung; Yang, Suk-Kyun; Hong, Seung-Mo; Park, Soo-Kyung; Kim, Jong Wo 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 204 KB

Non-smoking and concurrent immunosuppres

Non-smoking and concurrent immunosuppressive use are predictors of response to infliximab in patients with Crohn’s disease

✍ M.A Parsi; S Richardson; J.P Achkar; J Katz; D Seidner; J.F.G Orozco; B Lashner; 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 30 KB